Navigation and service

Projects GO-Bio initial

FungiMAB-2: Targeting Deadly Fungal Infections: A New Class of Antifungal Biologics : Date:

The FungiMAB-2 project is developing innovative biologics that block immune evasion proteins used by dangerous fungi like Candida albicans and Aspergillus fumigatus. This new therapeutic approach offers hope for patients with invasive fungal infections—especially those with weakened immune systems.

Bone2Gene-2: AI-Powered Diagnosis for Rare Bone Disorders : Date:

The Bone2Gene project is developing an AI-driven tool to drastically shorten the diagnostic journey for children with genetic bone dysplasia. By recognizing disease patterns in medical images, this technology enables earlier treatment access and supports clinical trial recruitment.

Cas13-based therapeutic approach for the acute treatment of viral infections : Date:

Helmholtz Zentrum München German Research Centre for Environmental Health (GmbH) - Dr Christoph Gruber

Development of drug candidates for a causal therapy of type 2 diabetes mellitus : Date:

Research Centre Jülich GmbH - Dr Sarah Schemmert

Customised immunoassays and screening platforms using DNA nanorobotics : Date:

Technical University of Munich - Dr Enzo Kopperger

Virus-free gene therapy for retinal diseases : Date:

Eberhard Karls University of Tübingen - Prof Peer Fischer

PureEx - Acoustofluidic purification of biomarkers for diagnostics : Date:

Leibniz Institute for Solid State and Materials Research Dresden e. V. (IFW Dresden e.V.) - Dr Stefanie Hartmann

Prevention of childhood asthma with extracts from cowshed dust : Date:

Helmholtz Zentrum München German Research Centre for Environmental Health (GmbH) - Prof. Dr Erika von Mutius

RNA-based diagnostics for the early detection of dementia risk : Date:

German Centre for Neurodegenerative Diseases - Dr Farahnaz Sananbenesi

Clarification of strategic questions for macrophage cell therapy : Date:

Dresden University of Technology - Prof Dr Michael Sieweke

Plug & play toolbox for highly efficient CRISPR genome modification : Date:

Max Planck Society for the Advancement of Science (MPG) - Dr Stephan Riesenberg

New antibiotics against resistant pathogens : Date:

Justus Liebig University Giessen - Prof Dr Till Schäberle

Single-cell immunoassay to quantify cytokine secretion : Date:

Ludwig-Maximilians University of Munich – Dr. Philip-Harald Böhm

Smart biofilms in hygiene and medicine : Date:

Bonn-Rhein-Sieg University of Applied Sciences – Prof. Martin Sieber

Genomic sequence selection – Towards molecular diagnostics : Date:

Twincore, Zentrum für Experimentelle und Klinische Infektionsforschung GmbH – Dr. Jelena Erdmann

Platform technology in-a-box screening system for cancer immunotherapy : Date:

Fraunhofer Institute for Cell Therapy and Immunology (IZI) – Dr. Sandy Tretbar

3D physioxia assays as a platform for substance testing under physiological conditions : Date:

Karlsruhe Institute of Technology – Christoph Grün

Cannula for catheter-based treatment of pathologies of the right heart under direct vision : Date:

Freiburg University Hospital – Prof. Dr. med. Wolfgang Bothe

Model-based in silico optimisation of drug dosages and dosing regimens : Date:

Helmholtz-Zentrum für Infektionsforschung GmbH – Dr. Majid Abedi

Highly effective cancer treatment with micron-wide X-ray flashes : Date:

Rechts der Isar University Hospital of the Technical University of Munich – Dr. Stefan Bartzsch

Search results 21 to 40 from a total of 84